Making styrene from biomaterials would bring big benefits


November 28, 2011

Styrene is one of the major building-block chemicals used to make many of the rubbery polymers and plastic materials we use today. More than 6 billion tons of it is manufactured each year in the United States alone, most of which goes into producing insulating materials, automobile tires, footwear, medical devices and hundreds of other widely used products.

The problem is that all styrene is currently derived from a dwindling resource – petroleum – and its production requires one of the most energy-intensive processes in the petrochemical manufacturing industry. More than three metric tons of steam is necessary to produce just one metric ton of styrene. David Nielsen styrene project Download Full Image

That excessive energy consumption also produces significant amounts of carbon dioxide, contributing to the detrimental buildup of greenhouses gases in the atmosphere.

At Arizona State University, David Nielsen and Rebekah McKenna are seeking ways to make styrene – and other common petrochemicals – using renewable resources. They want to produce materials that are more sustainable, require less energy to produce, and alleviate negative environmental impacts when they are manufactured.

Nielsen is an assistant professor of Chemical Engineering in the School for Engineering of Matter, Transportation and Energy, one of ASU’s Ira A. Fulton Schools of Engineering. McKenna is studying to earn a doctoral degree in chemical engineering.

They’re experimenting with engineering microorganisms to act as catalysts for making styrene from renewable resources – in this case biological materials, like sugars from plants.

The bacteria they have genetically engineered for that purpose has drawn attention from peers in their field. A report on their work was first published in the international science and engineering journal Metabolic Engineering, and then later appeared in Nature Chemical Biology as a featured “research highlight." 

This past summer, McKenna was one of only a handful of student researchers selected by the Society for Industrial Microbiology to give a presentation at its annual meeting. Her report, “Styrene Biosynthesis from Renewable Resources,” earned the conference’s Best Student Oral Presentation award.

“What we’ve done is create a new metabolic pathway,” Nielsen explains. “We’ve found the particular genes and enzymes required to achieve the necessary chemistry, and we have strung them together in a way that enables our engineered bacteria to function as a sort of biological catalyst.  In this way the cells can perform all of the biochemical reactions required to convert sugars like glucose into styrene.”

He and McKenna are doing what he describes as building “microscopic microbial chemical factories,” designed to synthesize the raw ingredients required to make products with characteristics identical to those that in the past have been derived only from petroleum.

If that is achieved, it could be possible for these chemicals produced from renewable materials to “plug directly into existing infrastructure, and be ready to use in current manufacturing systems that provide many of the products we use every day,” Nielsen says.

The next leap – a particularly challenging one – involves further improving the bacteria and scaling up the process to where styrene yields can be produced from renewable resources in as economically viable a way as styrene made from petroleum.  

Nielsen sees potential for his and McKenna’s research to contribute to engineering efforts to develop other commonly used chemicals, fuels, and materials from renewable resources that would “create whole new markets for renewable biochemicals and biopolymers.”  

At the very least, “we hope to be able to develop viable renewable alternatives for the bio-plastics industry,” he says. “From there, we might be able to begin making all sorts of new products from renewable, biological materials,” including new kinds of fuels.

Joe Kullman

Science writer, Ira A. Fulton Schools of Engineering

480-965-8122

Research project earns Grand Challenges Explorations funding


November 28, 2011

ASU’s College of Technology and Innovation will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to test unorthodox ideas that address global health and development challenges.

Qiang “Shawn” Chen, professor and researcher at ASU’s College of Technology and Innovation, will pursue an innovative global health research project on alternative delivery of human milk proteins to infants in developing countries. Download Full Image

Grand Challenges Explorations funds scientists and researchers worldwide to explore ideas that can break the mold in how we solve persistent global health and development challenges. Chen’s project is one of 110 Grand Challenges Explorations grants that were selected from 2,075 submitted proposals. 

“We believe in the power of innovation – that a single bold idea can pioneer solutions to our greatest health and development challenges,” said Chris Wilson, director of Global Health Discovery for the Bill & Melinda Gates Foundation. “Grand Challenges Explorations seeks to identify and fund these new ideas wherever they come from, allowing scientists, innovators and entrepreneurs to pursue the kinds of creative ideas and novel approaches that could help to accelerate the end of polio, cure HIV infection or improve sanitation.”

Projects that are receiving funding show promise in tackling priority global health issues where solutions do not yet exist. Chen’s research is aimed at improving infant health in developing countries by creating an alternative human milk protein delivery system in edible plants that is sustainable, readily accessible and available and cost effective. Chen is producing a cocktail of human milk proteins that will be engineered into the protein bodies of common plants such as lettuce or rice that can be consumed directly or formulated into baby food.

The suite of human milk proteins will enhance infant immune systems by providing essential nutrients, natural antibacterial and antiviral activities, and increasing the absorption of other essential nutrients.

“The goal for this project is to create an innovative, yet sustainable and accessible, solution to a global issue,” said Chen. “In this case it’s malnutrition and associated diseases such as iron deficiency anemia in infants of developing countries. By engineering edible plants to express the same natural proteins found in human milk, we are creating a viable solution for areas with limited resources to still provide the vital nutritional and medical benefits essential to an infant’s development and well-being."